Results 101 to 110 of about 4,243 (223)
Objectives Sjögren's syndrome (SS) is an autoimmune disease that causes chronic inflammation of the salivary glands leading to secretory dysfunction.
Venkata Kashyap Yellepeddi +1 more
doaj +1 more source
Laser Acupuncture on the Management of Xerostomia in Sjögren's Disease: A Randomized Clinical Trial
ABSTRACT Objectives This study evaluated the efficacy of photobiomodulation (PBM) at acupuncture points for managing xerostomia in patients with Sjögren's Disease. Material and Methods In this randomized, double‐blind clinical trial, 50 patients were assigned to PBM group (n = 22) or sham‐PBM group (n = 28).
Matheus Ferreira Linares +5 more
wiley +1 more source
Periodontal Disease and Salivary Gland Dysfunction in Neurofibromatosis Type 1: A Case–Control Study
ABSTRACT Objectives Neurofibromatosis type 1 (NF1) presents with diverse systemic and oral manifestations. The aim of this study was to investigate the periodontal status and salivary alterations in NF1 individuals. Methods A total of 38 individuals with NF1 diagnostic criteria were compared with a control group paired by age and sex.
Eloá Borges Luna +6 more
wiley +1 more source
ABSTRACT Objective To synthesize evidence on spirituality in patients with head and neck cancer (HNC), focusing on its dimensions, assessment strategies, and impact on health outcomes. Methods A comprehensive search of PubMed, Embase, LILACS, Web of Science, Scopus, and gray literature identified qualitative and quantitative studies explicitly ...
Liliana Wolf Braun +8 more
wiley +1 more source
Background: This study is centered on finding the changes in the lifestyle of individuals under polypharmacy by using specific questions about the effects of hyposalivation and collection of saliva.
J Juliet Philo D Almeida +3 more
doaj +1 more source
Salivary stimulation by prolonged release of pilocarpine in Sjögren’s syndrome.
Introduction: Prolonged drug delivery in the oral cavity offers many advantages, such as reducing adverse effects. Pilocarpine is an FDA-approved parasympathomimetic drug for the treatment of glandular hypofunction; however, its adverse effects limit its
Jesús Rodríguez-Pulido +5 more
doaj +1 more source
Oral Health Screening Prior to Oncological Treatment—The Helsinki Protocol
ABSTRACT Objectives Oncological treatments can have adverse effects on oral health and cause long‐term complications such as osteonecrosis. This retrospective study investigated the oral health of head and neck cancer patients before radiotherapy and patients with multiple myeloma, breast, prostate, lung, and kidney cancers before antiresorptive ...
Jemina Järvinen +4 more
wiley +1 more source
Xerostomia and hyposalivation in the elderly
La sécheresse buccale est plus répandue chez le sujet âgé. Cette pathologie est liée à l’âge, aux médicaments, à la maladie et à d’autres facteurs et peut avoir un retentissement sur la santé ainsi que sur la qualité de vie des patients âgés.Le manque de
Pierrard, Loïc
core
Drug‐Induced Sialolithiasis—A Big‐Data Retrospective Study
ABSTRACT Background Sialolithiasis pathophysiology is multifactorial, with systemic medications often hypothesised as a key contributor, particularly in older adults (Drug‐Induced Sialolithiasis). However, robust evidence supporting this theory is limited.
Gal Avishai +5 more
wiley +1 more source

